1993
DOI: 10.1002/hep.1840180602
|View full text |Cite
|
Sign up to set email alerts
|

Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection

Abstract: To evaluate the clinical significance of sequence variations in the hypervariable region of hepatitis C virus during the course of chronic infection, we performed pairwise comparison of the predominant nucleotide sequences. Hepatitis C virus RNA was extracted from two plasma samples obtained from 12 chronically infected Japanese patients over approximately 1 yr. Complementary DNA containing the hypervariable region was amplified by means of reverse transcription-polymerase chain reaction and was directly seque… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
51
2

Year Published

1996
1996
2004
2004

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 133 publications
(55 citation statements)
references
References 29 publications
2
51
2
Order By: Relevance
“…The HCV genome in single hosts is described as a dynamic population of different but closely related genomes designated quasispecies (Martell et al, 1992;Duarte et al, 1994;Domingo et al, 1998;Afonso et al, 1999). This quasispecies composition undergoes extensive variations during the course of chronic infection (Okamoto et al, 1992;Kurosaki et al, 1993;Farci et al, 1997;Afonso et al, 1999), which may result from the accumulation of random substitutions or from changes in the predominant quasispecies population under the selective pressure of the immune response (Lu et al, 2001). The HCV hypervariable region 1 (HVR1) is a 27 amino acid sequence located at the N terminus of glycoprotein E2 (Hijikata et al, 1991;Weiner et al, 1991;Kurosaki et al, 1993).…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…The HCV genome in single hosts is described as a dynamic population of different but closely related genomes designated quasispecies (Martell et al, 1992;Duarte et al, 1994;Domingo et al, 1998;Afonso et al, 1999). This quasispecies composition undergoes extensive variations during the course of chronic infection (Okamoto et al, 1992;Kurosaki et al, 1993;Farci et al, 1997;Afonso et al, 1999), which may result from the accumulation of random substitutions or from changes in the predominant quasispecies population under the selective pressure of the immune response (Lu et al, 2001). The HCV hypervariable region 1 (HVR1) is a 27 amino acid sequence located at the N terminus of glycoprotein E2 (Hijikata et al, 1991;Weiner et al, 1991;Kurosaki et al, 1993).…”
Section: Introductionmentioning
confidence: 99%
“…This quasispecies composition undergoes extensive variations during the course of chronic infection (Okamoto et al, 1992;Kurosaki et al, 1993;Farci et al, 1997;Afonso et al, 1999), which may result from the accumulation of random substitutions or from changes in the predominant quasispecies population under the selective pressure of the immune response (Lu et al, 2001). The HCV hypervariable region 1 (HVR1) is a 27 amino acid sequence located at the N terminus of glycoprotein E2 (Hijikata et al, 1991;Weiner et al, 1991;Kurosaki et al, 1993). HVR displays marked sequence variability, possibly corresponding to the emergence of immune escape mutants (Hijikata et al, 1991;Weiner et al, 1992;Kurosaki et al, 1993;Van Doorn et al, 1995;McAllister et al, 1998).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…16,17 Although this quasispecies nature of HCV is generated by the limited fidelity of RNA replication, host immunity, especially the humoral immune response, is thought to be one of the important driving forces in the sequence variations of the HVR of HCV. [18][19][20] We therefore compared the complexity of HVR 1 quasispecies of the HCV genome in serum, PBMCs, and liver to assess the pathogenic implication of HCV infection in PBMCs.…”
mentioning
confidence: 99%
“…SSCP analysis can fail to detect minor variants, i.e. sequences representing 5 % or less of the genomic population (Kurosaki et al, 1993). Failure to demonstrate a variant in plasma may therefore reflect a quantitative or a qualitative difference.…”
mentioning
confidence: 99%